These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6252316)

  • 1. High-pressure liquid chromatographic determination of ranitidine, a new H2-receptor antagonist, in plasma and urine.
    Mihaly GW; Drummer OH; Marshall A; Smallwood RA; Louis WJ
    J Pharm Sci; 1980 Oct; 69(10):1155-7. PubMed ID: 6252316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-pressure liquid chromatographic determination of cimetidine in plasma and urine.
    Mihaly GW; Cockbain S; Jones DB; Hanson RG; Smallwood RA
    J Pharm Sci; 1982 May; 71(5):590-2. PubMed ID: 7097510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography.
    Carey PF; Martin LE; Owen PE
    J Chromatogr; 1981 Sep; 225(1):161-8. PubMed ID: 6271798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid analysis of ranitidine in biological fluids and determination of its erythrocyte partitioning.
    Mullersman G; Derendorf H
    J Chromatogr; 1986 Sep; 381(2):385-91. PubMed ID: 3760093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of on-line high-performance liquid chromatography-mass spectrometry for the identification of ranitidine and its metabolites in urine.
    Martin LE; Oxford J; Tanner RJ
    Xenobiotica; 1981 Dec; 11(12):831-40. PubMed ID: 6281996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of ranitidine and its metabolites in human plasma and urine by high-performance liquid chromatography.
    Prueksaritanont T; Sittichai N; Prueksaritanont S; Vongsaroj R
    J Chromatogr; 1989 May; 490(1):175-85. PubMed ID: 2760148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of high-performance liquid chromatography-mass spectrometry for the study of the metabolism of ranitidine in man.
    Martin LE; Oxford J; Tanner RJ
    J Chromatogr; 1982 Apr; 251(2):215-24. PubMed ID: 6284777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for the determination of ranitidine and its metabolites in urine by h.p.l.c. and its application to study the metabolism and pharmacokinetics of ranitidine in man.
    Carey PF; Martin LE; Owen P
    Biochem Soc Trans; 1981 Feb; 9(1):112. PubMed ID: 6111505
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of ranitidine in plasma by high-performance liquid chromatography.
    Rahman A; Hoffman NE; Rustum AM
    J Pharm Biomed Anal; 1989; 7(6):747-53. PubMed ID: 2490777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of post-column fluorescence derivatization to develop a liquid chromatographic assay for ranitidine and its metabolites in biological fluids.
    Viñas P; Campillo N; López-Erroz C; Hernández-Córdoba M
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):443-9. PubMed ID: 9210451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of ranitidine in serum by high performance liquid chromatography.
    Vandenberghe HM; MacLeod SM; Mahon WA; Lebert PA; Soldin SJ
    Ther Drug Monit; 1980; 2(4):379-84. PubMed ID: 6111854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive determination of ranitidine in rabbit plasma by HPLC with fluorescence detection.
    Khedr A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):175-80. PubMed ID: 18166505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative analysis of ranitidine and its metabolites by high-performance liquid chromatography-mass spectrometry.
    Lant MS; Martin LE; Oxford J
    J Chromatogr; 1985 Apr; 323(1):143-52. PubMed ID: 4008551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of polymeric solid phase extraction and HPLC analysis for the determination of ranitidine in routine plasma samples obtained from paediatric patients.
    Hare LG; Millership JS; Collier PS; McElnay JC; Carson DJ; Shields MS
    J Pharm Pharmacol; 2001 Sep; 53(9):1265-72. PubMed ID: 11578109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of nizatidine and two of its main metabolites in human serum using high-performance liquid chromatography.
    Tracqui A; Kintz P; Mangin P
    J Chromatogr; 1990 Aug; 529(2):369-76. PubMed ID: 1977754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated solid-phase extraction and high-performance liquid chromatographic determination of ranitidine from urine, plasma and peritoneal dialysate.
    Karnes HT; Opong-Mensah K; Farthing D; Beightol LA
    J Chromatogr; 1987 Nov; 422():165-73. PubMed ID: 3437005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive and rapid determination of ranitidine in human plasma by HPLC with fluorescence detection and its application for a pharmacokinetic study.
    Ulu ST; Tuncel M
    J Chromatogr Sci; 2012 Apr; 50(4):301-6. PubMed ID: 22345389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine bioavailability and kinetics in normal male subjects.
    Garg DC; Weidler DJ; Eshelman FN
    Clin Pharmacol Ther; 1983 Apr; 33(4):445-52. PubMed ID: 6299642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.